Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07622797RecruitingPhase 2
Immunotherapy with chemotherapy and radiation for esophageal cancer
This trial tests a new immunotherapy drug (camrelizumab) combined with standard chemotherapy and radiation to treat advanced esophageal cancer while avoiding surgery if possible. The goal is to shrink the tumor and help you keep your esophagus working.
Luoyang, HenanAges 18 years+ - NCT03430037Enrolling by invitationPhase 2
Fisetin study to reduce frailty and inflammation in older women
This Phase 2 trial tests whether fisetin, a supplement, can reduce frailty and inflammation in postmenopausal women age 70 and older. If it works, it may help older adults feel stronger and have healthier body signals related to aging and inflammation.
Rochester, MinnesotaAges 70 years+ - NCT07061379Recruiting
Patient feedback in first-line lung cancer treatment study
This study collects patient feedback through questionnaires to see if it helps improve outcomes for people with advanced non-small-cell lung cancer starting chemo-immunotherapy. It may help your care team better understand how you are feeling.
Milan, ItalyAges 18 years+ - NCT07059793Recruiting
Study of a new mitral valve replacement for heart patients
This trial is testing a replacement valve (called MITRIS) for people whose own mitral valve or a previous artificial valve is not working well. The goal is to see how well the valve works over time after it is implanted.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07057622RecruitingPhase 3
Comparing a new radiation therapy and long-acting medication for neuroendocrine tumors
This phase 3 trial tests a radioactive drug (177Lu-DOTATATE) against a long-acting medication (Octreotide LAR) for people with advanced neuroendocrine tumors (NETs) that have grown despite standard treatment. The study aims to see which treatment works better and is safer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06861192RecruitingPhase 2/Phase 3
Fasudil and immunotherapy with hormone therapy for prostate cancer
This trial tests a new combination of drugs (Fasudil, a PD1 inhibitor, and hormone therapy) before prostate cancer surgery to see if it works better than standard treatment. It's for patients with early metastatic or locally advanced prostate cancer who haven't had any prior treatment.
Nanjing, JiangsuAges 18–85 - NCT07050537Recruiting
Oxygen levels for embryo growth in IVF treatment
This trial tests whether keeping embryos at a constant 5% oxygen is better than starting at 5% and lowering to 2% during IVF. It aims to find the best way to help your embryos develop and improve your chances of a successful pregnancy.
Zhengzhou, HenanAges 20–40 - NCT07621692RecruitingPhase 1
New radioactive therapy for advanced prostate cancer
This is an early-stage trial testing a new radioactive treatment (161Tb-PSMA) for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. The treatment targets cancer cells using a radioactive metal that may be more effective than older similar treatments.
TaipeiAges 20 years+ - NCT07037927Recruiting
Stay at work or return to work study (RETAIN)
This study helps Minnesotans who are working or want to work but have a health issue that makes it hard to keep working. It tests a support program to help you stay employed or get back to work.
Rochester, MinnesotaAges 18 years+ - NCT07033013Recruiting
Study of an oral supplement for menopause hot flashes
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
San Francisco, CaliforniaAges 40–65 - NCT07027709Recruiting
Hybrid ceramic veneers for better smiles
This trial tests how well hybrid ceramic laminate veneers work for fixing front teeth. It may help if you need cosmetic improvement and your teeth are healthy enough.
CairoAges 21 years+ - NCT07024667Recruiting
Laser treatment study for vaginal atrophy symptoms
This trial tests a carbon dioxide laser (FemiLift) to see if it can help women with vaginal dryness, burning, itching, or pain during sex caused by menopause. It aims to improve symptoms without hormones.
HaderaAges 45–75 - NCT03959878Recruiting
Test of a constant-pressure skin disk for feeding tubes
This study looks at whether a small constant-pressure skin device (a “skin disk”) is safe and practical when placed in people getting PEG or PEJ feeding tubes. If you qualify, it may help improve comfort and care around the tube site.
Rochester, MinnesotaAges 22 years+ - NCT06863844Recruiting
DNA markers for predicting outcomes in urothelial cancer
This trial studies DNA markers in tumor tissue or blood samples to see if they can predict how well treatments work or how the cancer behaves. It may help doctors better understand and manage urothelial cancer in the future.
BolognaAges 18 years+ - NCT06749431Enrolling by invitation
Meniscus transplant study: long-term outcomes
This study looks at how well meniscus transplants work over time — including how long the graft lasts and how it protects knee cartilage. It may be a good fit if you are getting your first or a repeat meniscus transplant, sometimes along with other knee repairs.
Plano, TexasAges 10–65 - NCT07019428Recruiting
A new way to stabilize gum grafts with titanium tacs
This trial tests a method using small titanium tacs to hold a gum graft in place instead of stitches. It may help people with thin gum tissue around dental implants have a more comfortable and effective procedure.
CairoAges 18–40 - NCT07018713RecruitingPhase 3
Testing Xeomin injections to prevent chronic migraine
This trial tests if Xeomin (a botulinum toxin injection) can help prevent chronic migraine. If you have frequent migraine headaches, you may be able to join.
Chandler, ArizonaAges 18 years+ - NCT07018245RecruitingPhase 2
TJ0113 Capsule for depression: a phase 2 study
This trial tests an investigational medication called TJ0113 for people with moderate to severe depression. It aims to see if the drug can safely improve depression symptoms when other treatments are stopped during the study.
Hangzhou, ZhejiangAges 18–65 - NCT06588998RecruitingPhase 2
Gum graft vs. special membrane for implant gum recession
This study tests whether a special membrane made from animal tissue (xenogenic cortical membrane) works as well as a gum graft (connective tissue graft) to fix gum recession around dental implants. If you have thin gums and an implant with receding gum, this trial may help cover the exposed implant surface.
Tanta, Gharbia GovernorateAges 20–50 - NCT07011186RecruitingPhase 1/Phase 2
TQB3909 and azacitidine for myeloid cancers
This trial tests a new oral drug, TQB3909, combined with a standard chemotherapy drug (azacitidine) for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The goal is to see if this combination is safe and effective.
Bengbu, AnhuiAges 18 years+ - NCT06590532Recruiting
Testing a new X-ray system for vascular surgery
This study compares a new automated X-ray system (mobile hybrid room) with the current standard equipment used during vascular surgery. It aims to see if the new system is more effective and cost-efficient for treating narrowed or widened blood vessels in the belly area.
Besançon, BesançonAges 18 years+ - NCT07229950RecruitingPhase 2
Experimental tablet for moderate to severe Ulcerative Colitis
This trial tests an experimental tablet, HRS-7085, for people with moderate to severe Ulcerative Colitis who haven't gotten enough help from standard treatments. The goal is to see if the drug can reduce inflammation and improve symptoms.
Chengdu, SichuanAges 18–75 - NCT07264127Recruiting
I-arch system for early orthodontic treatment
This study tests a new orthodontic tool, the I-arch system, for straightening the lower front teeth when they are moderately crowded. It aims to see how well the I-arch works during the first stage of braces treatment.
KarbalaAges 12 years+ - NCT07747519Enrolling by invitation
Mobile van visits for postpartum checkups
This study tests whether a mobile van can make it easier to attend your postpartum checkup after having a baby. If you qualify, you might get your checkup at a van near your home instead of having to travel to the hospital.
Providence, Rhode IslandAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.